Home Alzheimer’s Disease FDA Approves Rucaparib for Adult Patients with BRCA+ mCRPC

FDA Approves Rucaparib for Adult Patients with BRCA+ mCRPC

The FDA approved rucaparib (Rubraca) for the treatment of adult patients with a deleterious BRCA mutation (germline and/or somatic)-associated metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor-directed therapy and a taxane-based chemotherapy. 

This indication was approved under accelerated approval based on the objective response rate (ORR) and duration of response (DOR) data observed in the multi-center, single arm TRITON2 clinical trial.

“Standard treatment options for men with mCRPC have been limited to androgen receptor-targeting therapies, taxane chemotherapy, Radium-223 and sipuleucel-T,” Wassim Abida, MD, medical oncologist at Memorial Sloan Kettering Cancer Center and principal investigator for the TRITON2 study, said in a press release. “[Rucaparib] is the first in a class of drugs to become newly available to…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Reflections on Living With an Incurable Illness : braincancer

(I’ve checked with the moderators to make sure this is appropriate and a good fit for this subreddit. I'm a very private person, and...

This Foramen Magnum Meningioma almost killed me 18 years ago.

submitted by /u/dkrem Continue Reading to the Source

Patients, Family & Friends, and Healthcare professionals : braincancer

I am currently a PhD student based at the Marie Curie Palliative Care Research Centre at Cardiff University. My PhD is focussed on developing...

32 year old singer Tom Parker of The Wanted diagnosed with stage 4 glioblastoma

submitted by /u/Jexlan Continue Reading to the Source

Recent Comments